Pharmaceutical

Amneal files again for FDA approval of first dihydroergotamine autoinjector

Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe autoinjector to treat tough-to-treat headaches.

Nov 23, 2024 - 06:00
Amneal files again for FDA approval of first dihydroergotamine autoinjector
Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe autoinjector to treat tough-to-treat headaches.
Read the original article

Tags:

Previous Article

Enveda raises $130m to advance AI-driven plant based drug development

Next Article

Zai Lab and Pfizer to commercialise XACDURO in China

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Biotechs investigate ways to adapt to new clinical trial regulation and economic flux

Biotechs investigate ways to adapt to new clinical tria...

Sep 20, 2024

CDC says it’s too soon to assess risk posed by new Covid subvariant

CDC says it’s too soon to assess risk posed by new Covi...

Aug 23, 2023

CAR-T therapies and cancer risk: No easy answers for the FDA

CAR-T therapies and cancer risk: No easy answers for th...

Jan 27, 2024